Exagen (XGN) Net Cash Flow (2018 - 2026)

Exagen (XGN) has reported Net Cash Flow for 9 consecutive years, with -$10.7 million the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$10.7 million, up 1.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.3 million (up 164.2% YoY), and the FY2025 annual result was $10.2 million, up 170.44% from the prior year.
• Net Cash Flow was -$10.7 million for Q1 2026 at Exagen, down from -$3.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $18.8 million in Q2 2025 and troughed at -$20.7 million in Q2 2023.
• Average Net Cash Flow over 5 years is -$4.6 million, with a median of -$6.3 million recorded in 2022.
• The widest YoY moves for Net Cash Flow: up 775.72% in 2025, down 343300.0% in 2025.
• Over 5 years, Net Cash Flow stood at -$6.3 million in 2022, then jumped by 227.44% to $8.0 million in 2023, then tumbled by 99.99% to $1000.0 in 2024, then sank by 343300.0% to -$3.4 million in 2025, then slumped by 211.98% to -$10.7 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$10.7 million in Q1 2026, -$3.4 million in Q4 2025, and $5.6 million in Q3 2025.